A previous study performed in our laboratory demonstrated that mice vaccinated with recombinant AdsA (rAdsA) induced high titers of anti-AdsA antibodies and provided consistent protection in three mouse infection models under conditions of challenge with S. aureus clinical isolates (19). The gene discussed is RNF170; the disease is infection.